Ditchcarbon
  • Customers
  1. Organizations
  2. CollPlant
Public Profile
Pharmaceutical Preparation Manufacturing
IL
updated 5 days ago

CollPlant

Company website

CollPlant Biotechnologies Ltd., headquartered in Israel, is a pioneering company in the regenerative medicine and tissue engineering sectors. Founded in 2004, CollPlant has made significant strides in developing innovative solutions for wound healing and organ regeneration, leveraging its proprietary recombinant human collagen technology. The company’s core products include advanced wound care solutions and potential therapeutic applications for various medical conditions. What sets CollPlant apart is its unique ability to produce collagen through a plant-based system, ensuring a sustainable and biocompatible alternative to animal-derived collagen. With a strong market position, CollPlant has garnered attention for its groundbreaking research and development efforts, positioning itself as a leader in the biotechnology industry. Its commitment to enhancing patient outcomes through cutting-edge technology continues to drive its growth and influence in the field.

DitchCarbon Score

How does CollPlant's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

CollPlant's score of 25 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

45%

Let us know if this data was useful to you

CollPlant's reported carbon emissions

In 2023, CollPlant Biotechnologies Ltd., headquartered in Israel (IL), reported total carbon emissions of approximately 457,636.4 kg CO2e, comprising 74,588.2 kg CO2e from Scope 1 and 383,048.2 kg CO2e from Scope 2 emissions. This reflects a slight increase from 2022, when total emissions were about 439,930.0 kg CO2e, with Scope 1 emissions at 71,860.0 kg CO2e and Scope 2 emissions at 368,070.0 kg CO2e. In 2021, the company recorded total emissions of approximately 405,592.7 kg CO2e, indicating a trend of increasing emissions over the past three years. CollPlant has not disclosed any Scope 3 emissions data and has not set specific reduction targets or initiatives as part of its climate commitments. The company does not appear to inherit emissions data from any parent or related organizations, indicating that its reported figures are solely its own. Overall, while CollPlant has made strides in transparency regarding its emissions, the absence of reduction targets suggests a need for further commitment to climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

202120222023
Scope 1
62,137.8
00,000
00,000.0
Scope 2
343,454.9
000,000
000,000.0
Scope 3
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CollPlant's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CollPlant is in IL, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CollPlant is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Humabiologics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Zimmer Biomet

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 18 hours ago

Merz Pharma GmbH & Co. KGaA

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 18 hours ago

Illevax, Inc.

US
•
Computer and related services (72)
Updated 10 days ago

Mölnlycke Holding AB (publ)

SE
•
Health and social work services (85)
Updated 10 days ago

Galderma S.A.

CH
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250804.4
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy